436 related articles for article (PubMed ID: 15193410)
1. Biosafety aspects of the recombinant live oral Vibrio cholerae vaccine strain CVD 103-HgR.
Viret JF; Dietrich G; Favre D
Vaccine; 2004 Jun; 22(19):2457-69. PubMed ID: 15193410
[TBL] [Abstract][Full Text] [Related]
2. A review of the current status of enteric vaccines.
Levine MM; Noriega F
P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
[TBL] [Abstract][Full Text] [Related]
3. [Tolerance and immunogenicity of an oral dose of CVD 103-HgR, a live attenuated Vibrio cholerae 01 strain: a double-blind study of Chilean adults].
Lagos R; Avendaño A; Horwitz I; Prado V; Ferreccio C; Sotomayor V; Losonsky G; Wasserman SS; Cryz S; Kaper JB
Rev Med Chil; 1993 Aug; 121(8):857-63. PubMed ID: 8296092
[TBL] [Abstract][Full Text] [Related]
4. Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR.
Levine MM; Kaper JB; Herrington D; Ketley J; Losonsky G; Tacket CO; Tall B; Cryz S
Lancet; 1988 Aug; 2(8609):467-70. PubMed ID: 2900401
[TBL] [Abstract][Full Text] [Related]
5. Vibrio cholerae CVD103-HgR live oral attenuated vaccine: construction, safety, immunogenicity, excretion and non-target effects.
Cryz SJ; Kaper J; Tacket C; Nataro J; Levine MM
Dev Biol Stand; 1995; 84():237-44. PubMed ID: 7796960
[TBL] [Abstract][Full Text] [Related]
6. [Cholera update and vaccination problems].
Fournier JM; Villeneuve S
Med Trop (Mars); 1998; 58(2 Suppl):32-5. PubMed ID: 9812307
[TBL] [Abstract][Full Text] [Related]
7. Biosafety evaluation of recombinant live oral bacterial vaccines in the context of European regulation.
Favre D; Viret JF
Vaccine; 2006 May; 24(18):3856-64. PubMed ID: 16115705
[TBL] [Abstract][Full Text] [Related]
8. Development of Peru-15 (CholeraGarde), a live-attenuated oral cholera vaccine: 1991-2009.
Chowdhury MI; Sheikh A; Qadri F
Expert Rev Vaccines; 2009 Dec; 8(12):1643-52. PubMed ID: 19943759
[TBL] [Abstract][Full Text] [Related]
9. Palatability, reactogenicity and immunogenicity of engineered live oral cholera vaccine CVD 103-HgR in Chilean infants and toddlers.
Lagos R; San Martin O; Wasserman SS; Prado V; Losonsky GA; Bustamante C; Levine MM
Pediatr Infect Dis J; 1999 Jul; 18(7):624-30. PubMed ID: 10440439
[TBL] [Abstract][Full Text] [Related]
10. [Selection of attenuated Vibrio cholerae strains to obtain oral attenuated candidate vaccines against cholera].
María García H; Año G; Cedré B; Valmaseda T; Maestre JL; Díaz M; Mirabal M; Talavera A; García L
Rev Cubana Med Trop; 2005; 57(2):92-104. PubMed ID: 17966578
[TBL] [Abstract][Full Text] [Related]
11. Live attenuated oral cholera vaccines.
Ryan ET; Calderwood SB; Qadri F
Expert Rev Vaccines; 2006 Aug; 5(4):483-94. PubMed ID: 16989629
[TBL] [Abstract][Full Text] [Related]
12. Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform.
Liao J; Gibson JA; Pickering BS; Watnick PI
mSphere; 2018 Jun; 3(3):. PubMed ID: 29875145
[TBL] [Abstract][Full Text] [Related]
13. Randomized placebo controlled human volunteer trial of a live oral cholera vaccine VA1.3 for safety and immune response.
Mahalanabis D; Ramamurthy T; Nair GB; Ghosh A; Shaikh S; Sen B; Thungapathra M; Ghosh RK; Pazhani GP; Nandy RK; Jana S; Bhattacharya SK
Vaccine; 2009 Jul; 27(35):4850-6. PubMed ID: 19523608
[TBL] [Abstract][Full Text] [Related]
14. The current status of cholera vaccine development and experience with cholera vaccine trials in volunteers.
Levine MM; Kaper JB; Herrington D; Losonsky G; Tacket C; Tall B
Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):401-15. PubMed ID: 3217822
[TBL] [Abstract][Full Text] [Related]
15. Recombinant attenuated Vibrio cholerae strains used as live oral vaccines.
Kaper JB; Levine MM
Res Microbiol; 1990; 141(7-8):901-6. PubMed ID: 2101480
[TBL] [Abstract][Full Text] [Related]
16. [The current status of research on a cholera vaccine].
Fournier JM
Bull Soc Pathol Exot; 1998; 91(5 Pt 1-2):412-5. PubMed ID: 10078377
[TBL] [Abstract][Full Text] [Related]
17. Process development for a Cuban cholera vaccine based on the attenuated strain Vibrio cholerae 638.
Talavera A; Año G; García H; Moreira T; Delgado H; Riverón L; Gil S; Miranda A; Cedré B; Valmaseda T; Pino Y; Pérez JL; Infante JF; García L; Sierra G
Vaccine; 2006 May; 24(18):3746-9. PubMed ID: 16085342
[TBL] [Abstract][Full Text] [Related]
18. PaxVax CVD 103-HgR single-dose live oral cholera vaccine.
Levine MM; Chen WH; Kaper JB; Lock M; Danzig L; Gurwith M
Expert Rev Vaccines; 2017 Mar; 16(3):197-213. PubMed ID: 28165831
[TBL] [Abstract][Full Text] [Related]
19. Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children.
Suharyono ; Simanjuntak C; Witham N; Punjabi N; Heppner DG; Losonsky G; Totosudirjo H; Rifai AR; Clemens J; Lim YL
Lancet; 1992 Sep; 340(8821):689-94. PubMed ID: 1355798
[TBL] [Abstract][Full Text] [Related]
20. Current status of cholera and rise of novel mucosal vaccine.
Yamamoto T
Jpn J Infect Dis; 2000 Oct; 53(5):181-8. PubMed ID: 11135702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
